About GI GVHDGI GVHD is a debilitating and painful disease.

It is a common disease in immunocompromised cancer patients after allogeneic hematopoietic cell transplantation. Unlike organ transplants where the patient’s body organ, organ, in GVHD it is the donor cells to to attack the patient’s body. Most of the gastrointestinal tract, liver and skin In patients with mild to moderate GI GVHD typically develop symptoms of anorexia, nausea, vomiting and diarrhea. If left untreated, GI GVHD can progress to ulcerations in the lining of the gastrointestinal tract, and in its most severe form, can be fatal..

By its Biodefense Division, DOR is developing biomedical countermeasures after Project BioShield Act of 2004. DOR biodefense products in development are recombinant subunit vaccines to protect against the lethal effects of exposure to ricin toxin, botulinum toxin and anthrax protect. DOR the ricin toxin vaccine, RiVax has been shown that well tolerated and immunogenic in a Phase 1 clinical trial in healthy volunteers.The authors said their results support the need of future health inequities research and creative approaches check health inequalities across samples containing accounting to socioeconomic and social environmental factors. For more History out of the environment and socio-economic factors as volunteers Racial differences in diabetes prevalence is Roland J. Ph.D., Jessica E. Galarraga, MPH, Kelly M. RN and Tiffany L. Gary – Webb.